Bitoca, Faustina A.
HRN: 18-73-69 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/23/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
11/23/2023
11/29/2023
IVTT
300mg
Q6h
Invasive Carcinoma, Breast
Checking Final Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes